Effect of amiloride on experimental gentamicin nephrotoxicity

Jonathan Purnell, Donald Houghton, G. A. Porter, W. M. Bennett

Research output: Contribution to journalArticle

5 Citations (Scopus)

Abstract

Potassium and magnesium deficiency have been reported as risk factors for experimental gentamicin nephrotoxicity. Amiloride, a potassium-sparing diuretic, also leads to increased renal magnesium reabsorption. Amiloride, 2 mg/kg/day, was given to groups of 8-12 Fischer 344 rats receiving gentamicin, 20 mg/kg b.i.d., for 3, 7, 10 and 14 days. Control animals received the vehicle for gentamicin, amiloride alone or gentamicin alone. The degree of renal failure and weight loss were similar in gentamicin and gentamicin + amiloride groups at all time points despite increases in serum potassium and magnesium in the amiloride-treated animals. Tubular dysfunction as assessed by depression of renal cortical slice uptake of p-aminohippurate and N-methylnicotinamide was not improved by the addition of amiloride. In addition, a comparable degree of tubular necrosis and regeneration was observed in all gentamicin-treated groups. Maximum gentamicin concentrations in the renal cortex did not differ. Thus, despite reduction of urinary losses of potassium and magnesium with resultant increased serum values, amiloride did not protect against experimental gentamicin nephrotoxicity. The tubular electrolyte wasting noted clinically is likely to be a result, rather than a cause of proximal tubular cell damage.

Original languageEnglish (US)
Pages (from-to)166-170
Number of pages5
JournalNephron
Volume40
Issue number2
StatePublished - 1985

Fingerprint

Amiloride
Gentamicins
Magnesium
Potassium
Potassium Sparing Diuretics
Potassium Deficiency
Magnesium Deficiency
p-Aminohippuric Acid
Kidney
Inbred F344 Rats
Serum
Electrolytes
Renal Insufficiency
Weight Loss
Regeneration
Necrosis

ASJC Scopus subject areas

  • Nephrology

Cite this

Purnell, J., Houghton, D., Porter, G. A., & Bennett, W. M. (1985). Effect of amiloride on experimental gentamicin nephrotoxicity. Nephron, 40(2), 166-170.

Effect of amiloride on experimental gentamicin nephrotoxicity. / Purnell, Jonathan; Houghton, Donald; Porter, G. A.; Bennett, W. M.

In: Nephron, Vol. 40, No. 2, 1985, p. 166-170.

Research output: Contribution to journalArticle

Purnell, J, Houghton, D, Porter, GA & Bennett, WM 1985, 'Effect of amiloride on experimental gentamicin nephrotoxicity', Nephron, vol. 40, no. 2, pp. 166-170.
Purnell, Jonathan ; Houghton, Donald ; Porter, G. A. ; Bennett, W. M. / Effect of amiloride on experimental gentamicin nephrotoxicity. In: Nephron. 1985 ; Vol. 40, No. 2. pp. 166-170.
@article{a079621935b3461b8234cfc78f77dc18,
title = "Effect of amiloride on experimental gentamicin nephrotoxicity",
abstract = "Potassium and magnesium deficiency have been reported as risk factors for experimental gentamicin nephrotoxicity. Amiloride, a potassium-sparing diuretic, also leads to increased renal magnesium reabsorption. Amiloride, 2 mg/kg/day, was given to groups of 8-12 Fischer 344 rats receiving gentamicin, 20 mg/kg b.i.d., for 3, 7, 10 and 14 days. Control animals received the vehicle for gentamicin, amiloride alone or gentamicin alone. The degree of renal failure and weight loss were similar in gentamicin and gentamicin + amiloride groups at all time points despite increases in serum potassium and magnesium in the amiloride-treated animals. Tubular dysfunction as assessed by depression of renal cortical slice uptake of p-aminohippurate and N-methylnicotinamide was not improved by the addition of amiloride. In addition, a comparable degree of tubular necrosis and regeneration was observed in all gentamicin-treated groups. Maximum gentamicin concentrations in the renal cortex did not differ. Thus, despite reduction of urinary losses of potassium and magnesium with resultant increased serum values, amiloride did not protect against experimental gentamicin nephrotoxicity. The tubular electrolyte wasting noted clinically is likely to be a result, rather than a cause of proximal tubular cell damage.",
author = "Jonathan Purnell and Donald Houghton and Porter, {G. A.} and Bennett, {W. M.}",
year = "1985",
language = "English (US)",
volume = "40",
pages = "166--170",
journal = "Experimental Nephrology",
issn = "0028-2766",
publisher = "S. Karger AG",
number = "2",

}

TY - JOUR

T1 - Effect of amiloride on experimental gentamicin nephrotoxicity

AU - Purnell, Jonathan

AU - Houghton, Donald

AU - Porter, G. A.

AU - Bennett, W. M.

PY - 1985

Y1 - 1985

N2 - Potassium and magnesium deficiency have been reported as risk factors for experimental gentamicin nephrotoxicity. Amiloride, a potassium-sparing diuretic, also leads to increased renal magnesium reabsorption. Amiloride, 2 mg/kg/day, was given to groups of 8-12 Fischer 344 rats receiving gentamicin, 20 mg/kg b.i.d., for 3, 7, 10 and 14 days. Control animals received the vehicle for gentamicin, amiloride alone or gentamicin alone. The degree of renal failure and weight loss were similar in gentamicin and gentamicin + amiloride groups at all time points despite increases in serum potassium and magnesium in the amiloride-treated animals. Tubular dysfunction as assessed by depression of renal cortical slice uptake of p-aminohippurate and N-methylnicotinamide was not improved by the addition of amiloride. In addition, a comparable degree of tubular necrosis and regeneration was observed in all gentamicin-treated groups. Maximum gentamicin concentrations in the renal cortex did not differ. Thus, despite reduction of urinary losses of potassium and magnesium with resultant increased serum values, amiloride did not protect against experimental gentamicin nephrotoxicity. The tubular electrolyte wasting noted clinically is likely to be a result, rather than a cause of proximal tubular cell damage.

AB - Potassium and magnesium deficiency have been reported as risk factors for experimental gentamicin nephrotoxicity. Amiloride, a potassium-sparing diuretic, also leads to increased renal magnesium reabsorption. Amiloride, 2 mg/kg/day, was given to groups of 8-12 Fischer 344 rats receiving gentamicin, 20 mg/kg b.i.d., for 3, 7, 10 and 14 days. Control animals received the vehicle for gentamicin, amiloride alone or gentamicin alone. The degree of renal failure and weight loss were similar in gentamicin and gentamicin + amiloride groups at all time points despite increases in serum potassium and magnesium in the amiloride-treated animals. Tubular dysfunction as assessed by depression of renal cortical slice uptake of p-aminohippurate and N-methylnicotinamide was not improved by the addition of amiloride. In addition, a comparable degree of tubular necrosis and regeneration was observed in all gentamicin-treated groups. Maximum gentamicin concentrations in the renal cortex did not differ. Thus, despite reduction of urinary losses of potassium and magnesium with resultant increased serum values, amiloride did not protect against experimental gentamicin nephrotoxicity. The tubular electrolyte wasting noted clinically is likely to be a result, rather than a cause of proximal tubular cell damage.

UR - http://www.scopus.com/inward/record.url?scp=0021847386&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0021847386&partnerID=8YFLogxK

M3 - Article

C2 - 4000346

AN - SCOPUS:0021847386

VL - 40

SP - 166

EP - 170

JO - Experimental Nephrology

JF - Experimental Nephrology

SN - 0028-2766

IS - 2

ER -